About
Hypovolemia treatment
Areas of Focus
Categories
Small Molecule PharmaceuticalMidwest
Team (4)
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
66
By Phase
PHASE3: 1PHASE2: 1
By Status
RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06072430Lead Sponsor
A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)
PHASE3Recruiting
46 participants
Started: Aug 6, 2024 · Completed: Dec 31, 2025
NCT04257136Lead Sponsor
VBI-S for the Treatment of Hypotension in Hypovolemic Septic Shock Patients
PHASE2Active, not recruiting
20 participants
Started: Feb 17, 2020 · Completed: Dec 31, 2023
Locations (1)
Headquarters
Chicago, IL, United States
Map
Loading map...